Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Slutplattan FABKO 109085 AB
AB
Dissolved
Org 5591128532
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2017
1 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Slutplattan FABKO 109085 AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1M
1M
2M
2M
2M
2018
1M
2019
0M
2020
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2018
0M
2019
0M
2020
Income statement
SEK thousands
Item
2018
2019
2020
Revenue
1 721
1 253
388
Staff expenses
—
—
—
EBITDA
462
114
−164
Depreciation & amort.
−0
−0
−0
EBIT
462
114
−164
Net financials
—
—
−1
Profit before tax
346
86
−21
Tax
−76
−19
−0
Net profit
270
67
−21
Balance sheet
SEK thousands
Item
2018
2019
2020
Total assets
708
726
169
Equity
320
237
66
Long-term debt
0
0
0
Short-term debt
272
345
103
Total debt
272
345
103
Financial ratios
5-year trend
EBITDA margin
-42.3%
This company
15.8%
Market median
-368% vs market
2018
2020
Equity ratio
39.1%
This company
38.2%
Market median
+2% vs market
2018
2020
Return on equity
-31.8%
This company
18.4%
Market median
-273% vs market
2018
2020
Net profit margin
-5.4%
This company
8.1%
Market median
-167% vs market
2018
2020
Asset turnover
2.30×
This company
1.12×
Market median
+105% vs market
2018
2020
Debt / equity
1.56×
This company
0.62×
Market median
-152% vs market
2018
2020
Annual reports & filings
Annual report 2020
Filed via Bolagsverket / SCB · Period 2019-10-01 – 2020-09-30
View
PDF
Annual report 2019
Filed via Bolagsverket / SCB · Period 2018-10-01 – 2019-09-30
View
PDF
Annual report 2018
Filed via Bolagsverket / SCB · Period 2017-05-01 – 2018-09-30
View
PDF
More on Slutplattan FABKO 109085 AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network